No Data
No Data
No Data
Chimin Health Management Co., Ltd. (SHSE:603222) Stock Rockets 31% As Investors Are Less Pessimistic Than Expected
Chimin Health Management Co., Ltd. (SHSE:603222) shares have continued their recent momentum with a 31% gain in the last month alone. Not all shareholders will be feeling jubilant, since the share
Jimin Medical (603222.SH): The relevant cooperation with Boao International Hospital has ended, and the company has not promoted the transformation of its relevant scientific research results in China
Gelonghui, May 9, 丨 Jimin Medical (603222.SH) announced a stock trading risk warning notice. There are media reports that Professor Yin Hao's team from the Second Affiliated Hospital of the Naval Military Medical University (Shanghai Changzheng Hospital) and Professor Cheng Xin's team from the Chinese Academy of Sciences have successfully cured a type 2 diabetic with severe islet function impairment. Currently, the patient has been completely free from insulin for 33 months. The relevant results were published in the international journal “Cell Discovery”. At the same time, it was reported that Jimin Medical is Jon from the Department of Surgery and Biomedical Engineering at the University of California, Irvine
Jimin Medical (603222.SH): A total cost of 81.72 million yuan to buy back 1.934% of the shares
Gelonghui, April 30, 丨 Jimin Medical (603222.SH) announced that as of April 30, 2024, the company had repurchased 10,389,700 shares through centralized bidding transactions, accounting for 1.934% of the company's total share capital. The highest purchase price was 9.98 yuan/share, the lowest price was 5.00 yuan/share, and the total amount paid was 81,724,613.18 yuan (not including transaction fees).
Jimin Medical (603222.SH) reported first-quarter results, net profit of 148.669 million yuan, a year-on-year decrease of 55.92%
Jimin Medical (603222.SH) released its report for the first quarter of 2024. The company achieved operating revenue during the reporting period...
Retail Investors Among Chimin Health Management Co., Ltd.'s (SHSE:603222) Largest Stockholders and Were Hit After Last Week's 12% Price Drop
Key Insights Chimin Health Management's significant retail investors ownership suggests that the key decisions are influenced by shareholders from the larger public The top 9 shareholders own 51% of
Jimin Medical (603222.SH) has repurchased a total of 8.364,800 shares at a cost of 69.94 million yuan
Zhitong Finance App News, Jimin Medical (603222.SH) announced that as of March 31, 2024, the company had repurchased a total of 8.364,800 shares through centralized bidding transactions, accounting for 1.557% of the company's total share capital. The highest purchase price was 9.98 yuan/share, the lowest price was 5.00 yuan/share, and the total amount paid was 69.994 million yuan (excluding transaction fees).
No Data